Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
The 3 Best Russell 2000 Stocks to Buy in May 2024
06:55am, Friday, 10'th May 2024
Investing in Russell 2000 stocks is a smart idea because it focuses on small-cap stocks with substantial growth potential. While individual stocks within the index vary, some are poised to offer signi
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
10:34am, Thursday, 09'th May 2024
Investors are well aware of the explosive growth potential in weight loss drug stocks. That growth began last year with Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ).
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
02:04pm, Tuesday, 07'th May 2024
Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs.
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
11:33am, Tuesday, 07'th May 2024
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
06:49pm, Thursday, 02'nd May 2024
According to Harvard University, about two-thirds of United States adults are “overweight or obese,” while 36% are obese. And the university predicts that, at the current rate, about 50% of Americ
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
11:59am, Wednesday, 01'st May 2024
While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of reces
Is Viking Therapeutics Incredibly Undervalued?
10:30am, Sunday, 28'th Apr 2024
Viking Therapeutics has been one of the few standouts in healthcare this year. The company's experimental weight loss candidate has fueled a sharp uptick in its share price over the prior 13 months.
Can This High-Flying Stock 10x in 10 Years?
09:07am, Sunday, 28'th Apr 2024
Viking Therapeutics is developing two highly promising medicines. If the company succeeds, its share price will skyrocket even more.
3 Biotech Stocks to Buy on the Dip: April 2024
06:00am, Friday, 26'th Apr 2024
If you follow Warren Buffett's advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on the dip. Primarily, the thesis centers on the underlyin
3 Millionaire-Maker Biotech Stocks
10:30am, Thursday, 25'th Apr 2024
Oncology's future prominently features the kind of autoimmune R&D work that Iovance is doing. Helped by new technology, Recursion is using artificial intelligence to develop new drugs.
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
04:05pm, Wednesday, 24'th Apr 2024
Conference call scheduled for 4:30 p.m. ET today Results From Phase 2 VENTURE Trial of GLP-1/GIP Agonist VK2735 in Obesity Demonstrated Up to 13.1% Placebo-Adjusted Weight Loss (14.7% From Baseline) a
3 Biotech Stocks With Skyrocketing Potential: April 2024
11:36am, Wednesday, 24'th Apr 2024
Investing in biotech stocks is not for the faint of heart. The sector is prone to wild swings in stock prices, offering a distinctive blend of high risk and high reward.
Better Buy: Pfizer vs. Viking Therapeutics
09:15am, Tuesday, 23'rd Apr 2024
Shares of Pfizer and Viking Therapeutics have been on markedly different trajectories over the prior three years. In this comparison, Pfizer scans as a safer choice for cautious investors, while Vikin
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
07:00am, Tuesday, 23'rd Apr 2024
Many investors look to analysts' expectations to guide their movements each quarter. Typically, those investors can reasonably use estimates as a reference.
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
06:05am, Monday, 22'nd Apr 2024
The GLP-1 weight loss trend continues to flourish, and the ante keeps rising. The reigning champions in the battle of the bulge are Novo Nordisk A/V NYSE: NVO with its Semaglutide medications Ozempic
